Evidence map›Paper›PMID 41796393›Full record

ArticleBritish journal of haematology2026

Renal dysfunction in symptomatic Waldenström macroglobulinaemia: A nationwide Italian multicentre study.

Nicolò Danesin, Francesco Autore, Anna Maria Frustaci, Gianmarco Favrin, Emanuele Cencini, Alessandro Noto, Irene Dogliotti, Jacopo Olivieri, Marcello Riva, Isacco Ferrarini and 18 more

Abstract readMulticenter Study
In one paragraph

Article in British journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Nicolò DanesinDepartment of Medicine, University of Padova, and Hematology Unit Azienda Ospedale Università Padova, Padova, Italy.ORCID https://orcid.org/0009-0004-1352-306X
Francesco AutorePoliclinico Universitario A. Gemelli IRCCS Foundation, Rome, Italy.ORCID https://orcid.org/0000-0002-7868-7469
Anna Maria FrustaciNiguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.ORCID https://orcid.org/0000-0003-2587-7901
Gianmarco FavrinDivision of Hematology, Fondazione IRCSS San Matteo, Pavia, Italy.
Emanuele CenciniA.O.U. Senese and University of Siena, Siena, Italy.
Alessandro NotoHematology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Irene DogliottiDepartment of Molecular Biotechnologies and Health Sciences, University of Torino, Turin, Italy.ORCID https://orcid.org/0009-0004-0873-1622
Jacopo OlivieriAzienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
Marcello RivaAzienda ULSS 8 Berica, Ospedale S. Bortolo, Vicenza, Italy.
Isacco FerrariniDepartment of Engineering for Innovation Medicine, Section of Hematology, University of Verona, Verona, Italy.
Anna Maria BarbuiAzienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Sara SteffanoniU.O.C. Ematologia, Ospedale Valduce, Como, Italy.ORCID https://orcid.org/0000-0002-6314-0241
Dario MarinoOncology 1 Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
Benedetta PucciniDepartment of Hematology, AOU Careggi and University of Florence, Italy.
Piero Maria StefaniAzienda ULSS 2 Marca Trevigiana, Ospedale Ca Foncello, Treviso, Italy.ORCID https://orcid.org/0000-0003-2937-851X
Rita RizziHematology and Transplant Unit, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari "Aldo Moro", Bari, Italy.
Michele MerliHematology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Angela FerrariUniversity of Modena and Reggio Emilia, Reggio Emilia, Italy.
Stefano LuminariUniversity of Modena and Reggio Emilia, Reggio Emilia, Italy.ORCID https://orcid.org/0000-0001-8446-2285
Carlo ViscoDepartment of Engineering for Innovation Medicine, Section of Hematology, University of Verona, Verona, Italy.
Livio TrentinDepartment of Medicine, University of Padova, and Hematology Unit Azienda Ospedale Università Padova, Padova, Italy.
Andrea VisentinDepartment of Medicine, University of Padova, and Hematology Unit Azienda Ospedale Università Padova, Padova, Italy.
Annarita ConconiDivision of Hematology, Ospedale degli Infermi, Biella, Italy.
Simone FerreroDepartment of Molecular Biotechnologies and Health Sciences, University of Torino, Turin, Italy.ORCID https://orcid.org/0000-0002-9711-1502
Marzia VarettoniDivision of Hematology, Fondazione IRCSS San Matteo, Pavia, Italy.
Alessandra TedeschiNiguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Luca LaurentiPoliclinico Universitario A. Gemelli IRCCS Foundation, Rome, Italy.
Francesco PiazzaDepartment of Medicine, University of Padova, and Hematology Unit Azienda Ospedale Università Padova, Padova, Italy.ORCID https://orcid.org/0000-0002-2831-623X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prognostic significance of impaired renal function in Waldenström macroglobulinaemia (WM) remains poorly defined. We conducted a nationwide multicentre study to evaluate its clinical characteristics and prognostic impact in symptomatic patients. We analysed 402 symptomatic WM patients, stratified according to renal function at diagnosis (creatinine clearance <60 mL/min/1.73 m

Indexed as

Kidney DiseasesWaldenstrom MacroglobulinemiaAgedAged, 80 and overFemaleHumansItalyMaleMiddle AgedPrognosisB‐cell lymphomasIgM MGUSmonoclonal gammopathynon‐Hodgkin lymphomaplasma cell dyscrasiarenal insufficiencyWaldenström macroglobulinaemia

Identifiers

PMID41796393
PMCPMC13267470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.